Abstract
The effects of ceruletide on jejunal motility and experimentally induced pain were studied in 16 healthy men, who participated each in four experiments and received in random double blind fashion 5, 10, or 20 micrograms ceruletide intramuscularly or placebo. Jejunal pressures were recorded by three perfused catheters with orifices between 10 and 20 cm aboral of the ligament of Treitz. Ceruletide dose dependently diminished phase I and increased phase II type activity and tended to reduce the number, but not the duration, of activity fronts. The number and amplitude of contractions as well as the area under the curve increased significantly and dose dependently as did threshold and tolerance to electrically and threshold to thermally induced pain. Only mild sedative and other side effects occurred.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agosti A., Bertaccini G., Paulucci R., Zanella E. Caerulein treatment for paralytic ileus. Lancet. 1971 Feb 20;1(7695):395–395. doi: 10.1016/s0140-6736(71)92227-6. [DOI] [PubMed] [Google Scholar]
- Anastasi A., Erspamer V., Endean R. Isolation and amino acid sequence of caerulein, the active decapeptide of the skin of hyla caerulea. Arch Biochem Biophys. 1968 Apr;125(1):57–68. doi: 10.1016/0003-9861(68)90638-3. [DOI] [PubMed] [Google Scholar]
- Bernardi L., Bosisio G., De Castiglione R., Goffredo O. Synthesis of caerulein. Experientia. 1967 Sep 15;23(9):700–702. doi: 10.1007/BF02154120. [DOI] [PubMed] [Google Scholar]
- Bertaccini G., Agosti A. Action of caerulein on intestinal motility in man. Gastroenterology. 1971 Jan;60(1):55–63. [PubMed] [Google Scholar]
- Bueno L., Fioramonti J., Ruckebusch Y. Rate of flow of digesta and electrical activity of the small intestine in dogs and sheep. J Physiol. 1975 Jul;249(1):69–85. doi: 10.1113/jphysiol.1975.sp011003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Code C. F., Marlett J. A. The interdigestive myo-electric complex of the stomach and small bowel of dogs. J Physiol. 1975 Mar;246(2):289–309. doi: 10.1113/jphysiol.1975.sp010891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cornford E. M., Braun L. D., Crane P. D., Oldendorf W. H. Blood-brain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology. 1978 Oct;103(4):1297–1303. doi: 10.1210/endo-103-4-1297. [DOI] [PubMed] [Google Scholar]
- Debas H. T., Farooq O., Grossman M. I. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology. 1975 May;68(5 Pt 1):1211–1217. [PubMed] [Google Scholar]
- Dockray G. J., Gregory R. A., Tracy H. J., Zhu W. Y. Transport of cholecystokinin-octapeptide-like immunoreactivity toward the gut in afferent vagal fibres in cat and dog. J Physiol. 1981 May;314:501–511. doi: 10.1113/jphysiol.1981.sp013721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dollinger H. C., Berz R., Raptis S., von Uexküll T., Goebell H. Effects of secretin and cholecystokinin on motor activity of human jejunum. A radiotelemetering study of jejunal motility during secretin and cholecystokinin intravenous infusion. Digestion. 1975;12(1):9–16. doi: 10.1159/000197648. [DOI] [PubMed] [Google Scholar]
- Ferreira Montero V., Martínez Laganga A., Aznar García E. Usefulness of caerulein in the treatment of post-operative intestinal atony. J Int Med Res. 1980;8(1):98–104. doi: 10.1177/030006058000800118. [DOI] [PubMed] [Google Scholar]
- Fleckenstein P., Oigaard A. Effects of cholecystokinin on the motility of the distal duodenum and the proximal jujunum in man. Scand J Gastroenterol. 1977;12(3):375–378. doi: 10.3109/00365527709180944. [DOI] [PubMed] [Google Scholar]
- Gutiérrez J. G., Chey W. Y., Dinoso V. P. Actions of cholecystokinin and secretin on the motor activity of the small intestine in man. Gastroenterology. 1974 Jul;67(1):35–41. [PubMed] [Google Scholar]
- Kruse-Larsen C., Rehfeld J. F. Gastrin in human cerebrospinal fluid: lack of correlation with serum concentrations. Brain Res. 1979 Oct 26;176(1):189–191. doi: 10.1016/0006-8993(79)90885-0. [DOI] [PubMed] [Google Scholar]
- Labo G., Barbara L., Lanfranchi G. A., Bortolotti M., Miglioli M. MOdification of the electrical activity of the human intestine after serotonin and caerulein. Am J Dig Dis. 1972 Apr;17(4):363–372. doi: 10.1007/BF02231739. [DOI] [PubMed] [Google Scholar]
- Lahoda R., Stacher G., Bauer P. Experimentally induced pain: measurement of pain threshold and pain tolerance using a new apparatus for electrical stimulation of the skin. Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):51–56. [PubMed] [Google Scholar]
- Larsson L. I., Rehfeld J. F. Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res. 1979 Apr 13;165(2):201–218. doi: 10.1016/0006-8993(79)90554-7. [DOI] [PubMed] [Google Scholar]
- Madsen P. V., Lykkegaard-Nielsen M., Nielsen O. V. Ceruletide reduces postoperative intestinal paralysis. A double-blind placebo-controlled trial. Dis Colon Rectum. 1983 Mar;26(3):159–160. doi: 10.1007/BF02560160. [DOI] [PubMed] [Google Scholar]
- Mukhopadhyay A. K., Thor P. J., Copeland E. M., Johnson L. R., Weisbrodt N. W. Effect of cholecystokinin on myoelectric activity of small bowel of the dog. Am J Physiol. 1977 Jan;232(1):E44–E47. doi: 10.1152/ajpendo.1977.232.1.E44. [DOI] [PubMed] [Google Scholar]
- Rehfeld J. F., Larsson L. I., Goltermann N. R., Schwartz T. W., Holst J. J., Jensen S. L., Morley J. S. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature. 1980 Mar 6;284(5751):33–38. doi: 10.1038/284033a0. [DOI] [PubMed] [Google Scholar]
- Santamaria A., Lucani G., Montorsi M., Praga C. Action de la céuléine sur la colique hépatique. Nouv Presse Med. 1979 Jul 7;8(30):2482–2482. [PubMed] [Google Scholar]
- Scott L. D., Summers R. W. Correlation of contractions and transit in rat small intestine. Am J Physiol. 1976 Jan;230(1):132–137. doi: 10.1152/ajplegacy.1976.230.1.132. [DOI] [PubMed] [Google Scholar]
- Stacher G., Bauer P., Ehn I., Schreiber E. Effects of tolmetin, paracetamol, and of two combinations of tolmetin and paracetamol as compared to placebo on experimentally induced pain. A double blind study. Int J Clin Pharmacol Biopharm. 1979 Jun;17(6):250–255. [PubMed] [Google Scholar]
- Stacher G., Bauer P., Schneider C., Winklehner S., Schmierer G. Effects of a combination of oral naproxen sodium and codeine on experimentally induced pain. Eur J Clin Pharmacol. 1982;21(6):485–490. doi: 10.1007/BF00542043. [DOI] [PubMed] [Google Scholar]
- Stacher G., Steinringer H., Schmierer G., Schneider C., Winklehner S. Ceruletide decreases food intake in non-obese man. Peptides. 1982 Jul-Aug;3(4):607–612. doi: 10.1016/0196-9781(82)90158-9. [DOI] [PubMed] [Google Scholar]
- Stacher G., Steinringer H., Schmierer G., Winklehner S., Schneider C. Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man. Peptides. 1982 Nov-Dec;3(6):955–962. doi: 10.1016/0196-9781(82)90064-x. [DOI] [PubMed] [Google Scholar]
- Valenzuela J. E., Grossman M. I. Effect of pentagastrin and caerulein on intragastric pressure in the dog. Gastroenterology. 1975 Dec;69(6):1383–1384. [PubMed] [Google Scholar]
- Vantrappen G., Janssens J., Hellemans J., Ghoos Y. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977 Jun;59(6):1158–1166. doi: 10.1172/JCI108740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wingate D. L., Pearce E. A., Hutton M., Dand A., Thompson H. H., Wünsch E. Quantitative comparison of the effects of cholecystokinin, secretin, and pentagastrin on gastrointestinal myoelectric activity in the conscious fasted dog. Gut. 1978 Jul;19(7):593–601. doi: 10.1136/gut.19.7.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wohlzogen F. X., Weish P. Vergleichende Analgetikaprüfung unter Verwendung der Schmerzschwellenzeit bei thermischer Hautreizung als Kriterium für die analgetische Wirkung. Wien Klin Wochenschr. 1969 Aug 29;81(35):616–618. [PubMed] [Google Scholar]
- Zetler G. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8). Neuropharmacology. 1980 May;19(5):415–422. doi: 10.1016/0028-3908(80)90047-7. [DOI] [PubMed] [Google Scholar]